Last reviewed · How we verify
NCT03328065: EOLE
Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
trial testing Interviews in Non-resectable Metastatic Cancer of the Lung in 36 participants. Terminated before completion.
9 December 2020
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire Dijon |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 19 December 2017 |
| Primary completion | 9 December 2020 |
| Estimated completion | 19 December 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Interviews
- Questionnaires
Conditions studied
- Non-resectable Metastatic Cancer of the Lung — all drugs for Non-resectable Metastatic Cancer of the Lung →
- Non-resectable Metastatic Cancer of the Colon — all drugs for Non-resectable Metastatic Cancer of the Colon →
- Non-resectable Metastatic Cancer of the Rectosigmoid Junction — all drugs for Non-resectable Metastatic Cancer of the Rectosigmoid Junction →
- Non-resectable Metastatic Cancer of the Stomach — all drugs for Non-resectable Metastatic Cancer of the Stomach →
Sponsor
Centre Hospitalier Universitaire Dijon
Who can join
Eligibility, any sex, with Non-resectable Metastatic Cancer of the Lung or Non-resectable Metastatic Cancer of the Colon. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Reflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03328065
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interviews
Trials testing the same drug.
- NCT07105020 — iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer · NA · not yet recruiting
- NCT07105046 — Facilitators and Barriers to Cancer Treatment Among Texas Residents · NA · not yet recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
- NCT07158983 — Evaluation of a Child Health Care Program for Early Identification of Family Violence · not yet recruiting
- NCT07142005 — Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · recruiting
Other Centre Hospitalier Universitaire Dijon trials
Trials by the same sponsor.
- NCT06608004 — Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT06776848 — A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With · Phase 1, PHASE2 · recruiting
- NCT06347302 — Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment · NA · completed
- NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03328065 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Dijon
- Last refreshed: 21 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03328065.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing